Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers

Wallis, Robert S and Maeurer, Markus and Mwaba, Peter and Chakaya, Jeremiah and Rustomjee, Roxana and Migliori, Giovanni Battista and Marais, Ben and Schito, Marco and Churchyard, Gavin and Swaminathan, Soumya and Hoelscher, Michael and Zumla, Alimuddin (2016) Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers. The Lancet Infectious Diseases, 16 (4). e34-e46. ISSN 14733099

Archive 201641.pdf - Published Version Restricted to Registered users only Download (594kB) | Request a copy

Affiliation:	ICMR-National Institute for Research in Tuberculosis
Item Type:	Article
Uncontrolled Keywords:	Tuberculosis, drugs, treatment, regimens, host-directed therapies, biomarkers.
Subjects:	Tuberculosis > Clinical Research
Divisions:	Clinical Research
Depositing User:	Dr. Rathinasabapati R
Date Deposited:	11 Oct 2022 11:29
Last Modified:	11 Oct 2022 11:29
URI:	http://eprints.nirt.res.in/id/eprint/1456

Actions (login required)

View Item